ArticleNucleic acids research2026
Seedless 3' pairing enables miR-17 family miRNAs to seize let-7 target sites.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
MicroRNAs (miRNAs) are short noncoding RNAs that post-transcriptionally regulate gene expression. Their canonical function depends on a "seed" sequence at the miRNA 5' end that pairs with conserved sites in the 3' untranslated regions of target messenger RNAs to suppress gene expression. Although seed-mediated targeting is well characterized, the role of the miRNA 3' end remains poorly understood and is challenging to study. Here, we identify a noncanonical mechanism by which miR-106a, a member of the miR-17 family, competes with let-7a for binding to let-7 target sites despite their distinct seed sequences. This binding bypasses miR-106a seed pairing and instead relies on extensive complementarity at its 3' end, which shares sequence identity with the let-7a seed. Such binding of miR-106a does not itself silence these targets but shields them from let-7-mediated suppression, resulting in de-repression of let-7 targets. By contrast, miR-106b, which differs from miR-106a and the other miR-17 family members at its 3' end, lacks this de-repressive activity. These findings show that variation in miRNA 3' sequences can generate divergent functions within a miRNA family and underscore the need to account for 3'-end contributions when interpreting miRNA-target networks and considering the development of miRNA-based therapeutics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.